Amphastar Pharmaceuticals, Inc. - 8-K Filing
Amphastar's subsidiary IMS received an FDA warning letter on July 2, 2026 citing CGMP violations at its South El Monte facility. (Items: 8.01 Other EventsOn July 2, 2026, International Medication Systems, Limited (“IMS”), a subsidiary of the Company, received a warning letter (the)
Tickers: $AMPH